TP53 and metastatic malignant neoplasm in the lymph nodes: In the non-lymph node metastasis group, mutations are widely distributed on three conserved domains, P52_TAD (natively unfolded amino-terminal transactivation domain), P53 DNA-binding and P53_tetramer (tetramerization).